Long‐Term Outcomes Following Withdrawal of Anti‐Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long‐Term Study of GETECCU

In this extended analysis of patients included in the EXIT trial, withdrawing anti-TNF therapy in patients with IBD in remission was not associated with a higher long-term relapse risk.

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2025-05-02
DOI
https://doi.org/10.1111/apt.70172
Citations
3
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
5.45

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long‐Term Outcomes Following Withdrawal of Anti‐Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long‐Term Study of GETECCU

Sabino Riestra, Jordi Guardiola, Eduardo Leo‐Carnerero, Manuel Van Domselaar et al.
3 citations
Alimentary Pharmacology & Therapeutics
Inflammatory Bowel Disease
5.45
article

Long‐Term Outcomes Following Withdrawal of Anti‐Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long‐Term Study of GETECCU

Sabino Riestra, Jordi Guardiola, Eduardo Leo‐Carnerero, Manuel Van Domselaar, Mercè Navarro‐Llavat, Iván Guerra, Jésus Barrio, Javier P. Gisbert, María José Casanova, Cristina Rubín de Célix, Víctor Jair Morales-Alvarado, David Busquets, Míriam Mañosa, Marisa Iborra, María Dolores Martin‐Arranz, María Esteve, Daniel Ceballos, Ignacio Marín‐Jiménez, Ana Gutiérrez, María Chaparro, Alfredo José Lucendo, Manuel Barreiro‐de Acosta, Luis Ignacio Fernández-Salazar, Isabel Vera‐Mendoza, Iago Rodríguez–Lago, Óscar Nantes, Carmen Muñoz‐Villafranca, Natalia García‐Morales, Ana Garre, Montserrat Rivero, Pablo Navarro, J M Benítez, Inmaculada Alonso‐Abreu, Abdel Bouhmidi‐Assakali
article en
3 citations

Abstract

In this extended analysis of patients included in the EXIT trial, withdrawing anti-TNF therapy in patients with IBD in remission was not associated with a higher long-term relapse risk.

Alimentary Pharmacology & TherapeuticsVol. 62(1)
Universidad de Valladolid (ES), Universidad Francisco de Vitoria (ES), Hospital Universitario de Canarias (ES), Hospital Universitario La Paz (ES), Bellvitge University Hospital (ES), Hospital General Universitario Gregorio Marañón (ES), Hospital Universitari i Politècnic La Fe (ES), Hospital Universitario de Torrejón (ES), Hospital de Basurto (ES), Instituto Maimónides de Investigación Biomédica de Córdoba (ES), Hospital Clínico Universitario de Valencia (ES), Complejo Hospitalario Universitario de Santiago (ES), Hospital Universitario de Gran Canaria Doctor Negrín (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital General de Tomelloso (ES), Hospital General de Granollers (ES), Instituto de Investigación Marqués de Valdecilla (ES), Centro de Investigación Biomédica en Red (ES), Hospital de Galdakao (ES), Hospital Universitario Reina Sofía (ES), Mútua Terrassa (ES), Hospital Universitario de La Princesa (ES), Hospital de Sant Joan Despí Moisès Broggi (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Hospital General Universitario de Alicante Doctor Balmis (ES), Complexo Hospitalario Universitario A Coruña (ES), Hospital Universitario de Fuenlabrada (ES), Hospital Universitario Virgen del Rocío (ES), Hospital Universitari Germans Trias i Pujol (ES), Hospital Universitari de Girona Doctor Josep Trueta (ES), Hospital Clínico Universitario de Valladolid (ES), Hospital Universitario Río Hortega (ES), Servicio Gallego de Salud (ES), Instituto de Investigación Sanitaria del Principado de Asturias (ES), Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) (ES), Universidad Autónoma de Madrid (ES)
AbbVie, Instituto de Salud Carlos III
Good health and well-being
Openalex Percentile: Top 5%
Inflammatory Bowel Disease
5.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.